| Registered Number:07160040 |
For the year ended 28 February 2025
England and Wales
Unaudited Financial Statements
For the year ended 28 February 2025
RADMED Limited
Contents Page
1
Statement of Financial Position
2 to 3
Notes to the Financial Statements
RADMED Limited
Statement of Financial Position
2024
2025
| Property, plant and equipment |
14,999
10,178
2
-
20,000
3
34,999
10,178
| Trade and other receivables |
171,771
108,326
4
66,764
| Cash and cash equivalents |
69,841
178,167
238,535
| Trade and other payables: amounts falling due within one |
| year |
(25,205)
(23,247)
5
213,330
154,920
Net current assets
| Total assets less current liabilities |
189,919
223,508
| Trade and other payables: amounts falling due after more |
| than one year |
(16,399)
(6,560)
6
183,359
Net assets
207,109
100
100
183,259
207,009
183,359
207,109
Shareholders' funds
| For the year ended 28 February 2025 the company was entitled to exemption from audit under Section 477 of the Companies Act 2006 relating to small companies. |
| The members have not required the company to obtain an audit of its financial statements for the year ended 28 February 2025 in accordance with Section 476 of the Companies Act 2006 |
| The directors acknowledge their responsibilities for:a) ensuring that the company keeps proper accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and |
| b) preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of |
| each financial year and of its profit or loss for each financial year in accordance with the requirements of Section |
| 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial |
| statements, so far as applicable to the company. |
| In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered. |
| The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. |
| These financial statements were approved and authorised for issue by the Board on 28 July 2025 and were signed by: |
| The notes form part of these financial statements |
1 of 3
For the year ended 28 February 2025
RADMED Limited
Notes to the Financial Statements
Statutory Information
| RADMED Limited is a private limited company, limited by shares, domiciled in England and Wales, registration |
| number 07160040. |
5 Chigwell Road
London
E18 1LR
| The presentation currency is £ sterling. |
Basis of preparing the financial statements
| These financial statements have been prepared in accordance with the provisions of Section 1A of Financial |
| Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the |
| Companies Act 2006. The financial statements have been prepared under the historical costs convention as |
| modified by the revaluation of certain assets. |
Revenue recognition
| Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts. |
| 2. Property, plant and equipment |
32,742
21,157
11,067
518
9,820
3,837
4,808
1,175
1,693
15,875
24,994
42,562
| Provision for depreciation and impairment |
22,564
16,047
6,517
-
Charge for year
4,999
2,237
2,339
423
27,563
18,284
8,856
423
1,270
7,019
6,710
14,999
518
4,550
5,110
10,178
2 of 3
For the year ended 28 February 2025
RADMED Limited
Notes to the Financial Statements Continued
| 3. Investments held as fixed assets |
20,000
20,000
20,000
20,000
20,000
20,000
| 4. Trade and other receivables |
2024
2025
108,326
171,771
| 5. Trade and other payables: amounts falling due within one year |
2024
2025
-
(1)
| Taxation and social security |
22,953
24,858
294
348
23,247
25,205
| 6. Trade and other payables: amounts falling due after more than one year |
2024
2025
| Bank loans and overdraft (secured) |
6,560
16,399
| 7. Average number of persons employed |
During the year the average number of employees was 1 (2024 : 1)
3 of 3